GenexAI attends CSMD in London

About CSMD and our Participation

GenexAI had honor of attending and presenting at the 3rd Conference on Clinical Studies with Medical Devices and IVDs (CSMD) held in London in late May 2024. CSMD is one of the key industry events of the year, bringing together leading experts in the medical device and IVD sectors. The conference is a vital platform for discussing how to set up clinical and performance studies and implement regulations and guidelines, and optimizing data management, featuring high-quality participants and fostering significant industry advancements.

Insightful Presentations by Ciska Janssens-Böcker

Ciska Janssens-Böcker delivered two insightful presentations, sharing her expertise on the current industry landscape and the challenges faced by stakeholders. She highlighted the importance of demonstrating value with clinical endpoints and the importance of these endpoints to address unmet needs. Janssens-Böcker emphasized further how tools like GenexAI are instrumental in reducing the time on screening and reviewing evidence, resulting in credible and traceable results, supporting robust clinical evaluations and systematic literature reviews.

Positive Reception and Industry Impact

Her presentations resonated with the audience, demonstrating how GenexAI’s advanced AI solutions can simplify and solve complex industry problems. The feedback from industry peers was overwhelmingly positive, reflecting the value and relevance of the insights shared. The topics discussed in the talks reinforced among other ideas the importance of leveraging AI responsibly to drive innovation in medical device studies.

Importance of Attending CSMD

Attending CSMD is vital for companies like ours, providing a platform to exchange knowledge, network with industry leaders, and stay ahead of emerging trends. The positive feedback we got highlights the importance of understanding industry challenges and collaborating with key stakeholders. Our commitment to responsible AI and innovation proves that technology can effectively address and resolve many issues faced by the medical device and IVD sectors.

Leadership and Dedication

By participating in events like CSMD, GenexAI continues to demonstrate its leadership and dedication to advancing the field of clinical studies. The company remains at the forefront of ensuring that AI solutions are not only innovative but also ethically and responsibly applied to improve industry standards.

For more information about the conference, visit CSMD 2024. To learn more about GenexAI and their groundbreaking solutions, check out GenexAI.

Share Blog:

• Copy link:
• Share on Twitter:
• Share on Facebook:
• Share on LinkedIn: